Skip to main content

Royal Osteoporosis Society urges Britons to check bone health risk Gates Foundation and Wellcome Leap commit $100m to cut stillbirths Iridex MicroPulse TLT shows sustained IOP cuts in two-year study First Tracks' ANB033 hits goals in coeliac gluten challenge BridgeBio encaleret hits ADH1 endpoints as NDA earns Priority Review Acoramidis beats tafamidis on cardiac outcomes in real-world EHR study Claris Bio reports positive CSB-001 data in rare corneal disease InnoCare wins China IND approval for TL1A/IL-23p19 bispecific ICP-B161 SeaStar Medical secures ICD-10-PCS codes for SCD kidney therapy Idorsia aprocitentan shows double-digit BP cuts in obesity and CKM XORTX plans Health Canada CTA filing for gout candidate XRx-026 Freenome's updated SimpleScreen CRC test improves APL sensitivity NurExone advances ExoPTEN optic nerve programme to rabbit study Avaí Bio and Austrianova begin San Raffaele diabetes cell trial EliseAI partners with Nextech to embed voice AI in specialty clinics Royal Osteoporosis Society urges Britons to check bone health risk Gates Foundation and Wellcome Leap commit $100m to cut stillbirths Iridex MicroPulse TLT shows sustained IOP cuts in two-year study First Tracks' ANB033 hits goals in coeliac gluten challenge BridgeBio encaleret hits ADH1 endpoints as NDA earns Priority Review Acoramidis beats tafamidis on cardiac outcomes in real-world EHR study Claris Bio reports positive CSB-001 data in rare corneal disease InnoCare wins China IND approval for TL1A/IL-23p19 bispecific ICP-B161 SeaStar Medical secures ICD-10-PCS codes for SCD kidney therapy Idorsia aprocitentan shows double-digit BP cuts in obesity and CKM XORTX plans Health Canada CTA filing for gout candidate XRx-026 Freenome's updated SimpleScreen CRC test improves APL sensitivity NurExone advances ExoPTEN optic nerve programme to rabbit study Avaí Bio and Austrianova begin San Raffaele diabetes cell trial EliseAI partners with Nextech to embed voice AI in specialty clinics

Search

Sign in Create account

Subscribe

Main navigation

News
Sectors
Content
- Analysis
- Interview
- Opinion
- Podcast
- Video
- Webinar
Events
Newsletter
About
Contact

Breadcrumb

Home
Opinion

Opinion

Subscribe to Opinion

Subscribe to The Biotech Times

Email

The subscriber's email address.

Manage your newsletter subscriptions

Biotech Times — Daily Briefing (coming soon)

Biotech Times — Event Alerts

Biotech Times — Monthly Report

Biotech Times — Weekly Sector Digest

Select the newsletter(s) to which you want to subscribe.

Get the biotech news that matters — pick the briefings that suit you.

Sectors you’re interested in

Pick as many as you like — your digest will lead with stories from these sectors. Leave blank if you want everything.

Manage existing

Leave this field blank

Legal

Privacy Policy
Cookie Policy
Terms of Use
Acceptable Use Policy (Community Guidelines)
Copyright & Takedown Policy
Accessibility Statement

Editorial

AI Use Policy
Editorial Standards & Corrections Policy
Why we ask for your business email
Sponsored Content & Advertising Disclosure

© 2026 Disrupts Media Limited · Company No. 09447878

Registered office: 41 Luke Street, London EC2A 4DP, United Kingdom

hello@disruptsmedia.com · privacy@disruptsmedia.com